Novelos Therapeutics, Inc. was founded in 1996 to commercialize a promising, novel platform technology developed by BAM Ltd., a Russian biotechnology company. This platform has led to the identification of a novel class of metabolic modulators of cell cycle and function.
Contact Novelos Therapeutics:
